Latest Headlines

  1. Biolabs International's New App Cuts Clinic Visits, Expands Testing Access 8/19/2025

    Biolabs International LLC, a healthcare innovation company based in San Diego, California, is transforming how diagnostics are delivered and accessed , both in the home and in clinical research.

  2. Twist Bioscience Launches Oncology DNA CGP Panel To Advance Precision Medicine With Customizable, Platform-Agnostic NGS Solution 8/19/2025

    Twist Bioscience Corporation, a core mid-cap growth and value equity, in the life sciences segment of the health care sector, today launched the Twist Oncology DNA Comprehensive Genomic Profiling (CGP) Panel, a customizable, research-use-only solution designed to empower users to identify genomic alterations for a broad set of tumors, guide targeted therapy development and support clinical and translational oncology research.

  3. Biodesix Recognized As A Thermo Fisher Scientific Center Of Excellence (COE) For NGS Diagnostics 8/19/2025

    Biodesix, Inc. (Nasdaq: BDSX), a leader in personalized diagnostics, announced that the company is designated as a Thermo Fisher Scientific Center of Excellence (COE) as part of Thermo Fisher’s collaborative initiative to advance NGS-based diagnostics.

  4. Labcorp Launches First FDA-Cleared Blood Test For Alzheimer's Disease 8/18/2025

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid 42 Ratio, the first blood-based in-vitro diagnostic (IVD) test cleared by the U.S. Food and Drug Administration (FDA) to aid in the diagnosis of Alzheimer's disease through early detection of the amyloid plaques associated with the disease in appropriate patients.

  5. Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype For MTB On Rapid-Deploy SeekIt Platform 8/13/2025

    Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced a significant advancement in the global fight against tuberculosis (TB) with an investigational prototype for Mycobacterium tuberculosis (MTB) detection on its SeekIt platform.

  6. Techcyte And Modella AI Announce A Research Collaboration With Modella AI's State-Of-The-Art Agentic And Generative AI-Powered Diagnostic Pathology Platform 8/12/2025

    Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its platform, Techcyte Fusion (research use only (RUO) in the US, CE-IVDD-marked in Europe), now includes Modella AI, a biomedical artificial intelligence company at the forefront of computational pathology, as a partner in the Techcyte Fusion Partner Program.

  7. Copan Launches UriVerse™: Fully Automated Solution For Urine Specimen Aliquoting 8/12/2025

    Copan, a leader in microbiology laboratory and automation innovations, proudly announced the official launch of UriVerse™ during the Association for Diagnostics & Laboratory Medicine (ADLM) Clinical Lab Expo in Chicago, IL.

  8. Thermo Fisher Receives FDA Approval For NGS-Based Companion Diagnostic For New Non-Small Cell Lung Cancer Treatment 8/11/2025

    Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients who may be candidates for HERNEXEOS (zongertinib tablets), a tyrosine kinase inhibitor (TKI), developed by Boehringer Ingelheim.

  9. HistoIndex Marks Another Step Forward With FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis In Fibrosis Assessment 8/11/2025

    HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™ Plus, its second Laboratory Developed Test (LDT) available in the United States.

  10. Haier Biomedical Supports Macao's Key TCM Lab 8/8/2025

    The State Key Laboratory of Quality Research in Chinese Medicine (University of Macau)—one of the first state key laboratories established in Macao—is turning to Haier Biomedical's advanced equipment to help break through research bottlenecks in its traditional Chinese medicine (TCM) innovation.